[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2004028954A - Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method - Google Patents

Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method Download PDF

Info

Publication number
JP2004028954A
JP2004028954A JP2002189569A JP2002189569A JP2004028954A JP 2004028954 A JP2004028954 A JP 2004028954A JP 2002189569 A JP2002189569 A JP 2002189569A JP 2002189569 A JP2002189569 A JP 2002189569A JP 2004028954 A JP2004028954 A JP 2004028954A
Authority
JP
Japan
Prior art keywords
reagent
reaction
measurement
antibody
immunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002189569A
Other languages
Japanese (ja)
Inventor
Tadashi Yamazaki
山崎 忠
Hiroshi Matsui
松井 寛史
Yoshikatsu Sato
佐藤 良克
Yuichi Yamada
山田 祐一
Yumi Murakami
村上 由美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Seiken Co Ltd
Original Assignee
Denka Seiken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denka Seiken Co Ltd filed Critical Denka Seiken Co Ltd
Priority to JP2002189569A priority Critical patent/JP2004028954A/en
Publication of JP2004028954A publication Critical patent/JP2004028954A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To stabilize reaction and to enhance measurement accuracy by relaxing the effects of external variation factors on a reagent for an immunity measuring method comprising two liquids applicable to an autoanalyzer for biochemical inspection. <P>SOLUTION: This immunity measuring method is based on a condensation method using a first reagent including a buffer solution and a second reagent including an antibody or antigen. According to this immunity measuring method, measurement is performed by using an autoanalyzer and the first and second reagents are put in a reaction vessel. With respect to the amount of reagents added to a reaction system, the first reagent is equal to or more than 1.5 in volume relative to the second reagent, thereby stabilizing reaction and enhancing measurement accuracy. <P>COPYRIGHT: (C)2004,JPO

Description

【0001】
【発明の属する技術分野】
本発明は、生化学検査用自動分析装置に適応可能な2液からなる免疫測定法による試薬において、外的な変動要因による影響を緩和することで、反応を安定化し測定精度を向上するための方法に関する。
【0002】
【従来の技術】
免疫測定法は、血清および血漿、尿、髄液などの体液に含まれる抗原性物質又は抗体の定量方法として臨床検査に応用され、現在は生化学検査用自動分析装置に適応した方法が広く普及している。近年、臨床検査を目的とした免疫学的測定法は、不溶性担体を用いるなどして高感度化が実現されており、測定精度の向上は著しい。例えば、粒子径の異なる不溶性担体粒子を2種類以上使用する技術(特許第2588174号公報)などを用いて高感度な測定を可能とする試薬が多く開発されている。
しかしながら、高感度化により測定精度が向上されている試薬では、高感度であるが故に外的な要因の微かな変動が測定に影響を与えてしまうことがある。特に、温度条件が不安定な状態では測定値に変動を与えてしまう問題があった。
【0003】
測定に使用される生化学用自動分析装置には様々なものがあるが、試薬の分注方式で2つに分けることができる。一方はピペッティングにより試薬を分注する方式であり、試薬分注プローブと呼ばれる部分が試薬庫に置かれた試薬瓶から試薬を吸引し、それを反応槽へ吐出するものである。すなわち、試薬分注プローブが試薬保管庫と反応槽の間を往来して試薬の吸引と分注を行い、1本のプローブで数種類の異なる試薬の分注を行うものである。もう一方は、試薬庫に置かれた試薬瓶からチューブを介して反応槽へと分注する方式であり、試薬瓶から試薬を連続的に吸引し、反応槽へ連続的に吐出するものである。すなわち、チューブの一端で試薬の吸引、他の一端で分注を行い、一本のチューブにつき1試薬のみ運用されるものである。いずれの方法も試薬の吸引および吐出はシリンジ方式にて行われ、電磁弁より吸引と吐出の切替えが行われる。
これら2種類の装置のうち、チューブ方式の装置において測定開始後しばらくの間測定値が安定せず正確な定量ができないという問題があった。
【0004】
【発明が解決しようとする課題】
本発明は、生化学検査用自動分析装置による測定において、測定開始後測定値が安定しないという問題点を解決することを目的とする。具体的には、生化学検査用自動分析装置による測定において第2試薬の添加による反応液全体としての温度変化がもたらす測定精度の低下を抑えるために、反応を安定化する方法を提供することである。
【0005】
【課題を解決するための手段】
本発明者らは、上記問題を解決すべく鋭意検討を行い測定値が不安定になる原因を見出した。すなわち、上述の生化学用自動分析装置の試薬分注プローブ方式、チューブ方式のいずれの装置でも、試薬を安定に維持するために試薬を設置する試薬庫は冷却されているものが多く、試薬は低温に保たれる。しかしながら、試薬分注部においては事実上冷却が不可能であり、特に反応の場である反応槽は37℃に保たれた恒温槽内にあり、反応槽に近い試薬分注部先端は比較的高温の状態に置かれている。
【0006】
ピペッティング方式の装置では、試薬の吸引から吐出までのタイミングが一定であり、常に同じ条件で試薬が分注されるが、チューブ方式の装置では、装置が停止している状態から測定を開始する場合と連続的に試薬を吐出している場合とで、分注される試薬の温度が異なる。すなわち、装置停止状態では保冷庫から反応槽を連絡しているチューブ内の試薬はチューブ内に滞留して室温条件におかれるので、装置の運転を開始した場合、当初は室温まで加温された試薬が反応系に添加されるが、やがて保冷庫内で低温条件におかれていた試薬が加温されることなく反応系に添加される。
【0007】
前記免疫測定法をチューブ方式の装置にて運用する場合、反応槽内では先ず被検試料と緩衝液である第1試薬が混合され、通常37℃で約5分間インキュベーションされ、試料と第1試薬の混合物は37℃に加温される。その後、抗原抗体反応に直接関与する成分を含む第2試薬が添加されるが、第2試薬の温度が低い場合、反応液全体としての温度変動を引き起こし、反応に影響を与える。このため、反応系は、このような温度変化をも勘案して確立される。しかし、上述のように、装置運転直後とある程度の時間が経過した後での、反応系に添加される第2試薬の温度に差があると反応系が安定せず、測定値が異なることとなり、測定精度の低下を引き起こしてしまう。
【0008】
この原因解明を踏まえ、本願発明者らは、第2試薬の添加による温度変化の影響を低減するための検討を行った結果、反応時の温度条件を安定化するためには第1試薬量と第2試薬量の比を工夫すればよいことを見出した。
すなわち、反応に先だって37℃に加温される第1試薬の割合を多くすることにより、第2試薬の温度差により生じる反応液全体としての温度変化を抑えることが可能になることを見出した。本願発明者らは、第1試薬及び第2試薬の容積比について鋭意検討を行った結果、本願発明を完成させるに至った。
【0009】
さらに、本願発明者らは上述の反応系の不安定さによる測定精度の低下の問題を別のアプローチから解決しようと試み、第2試薬を保冷庫に保存せず、あらかじめ温度を上げておくことにより、測定精度の低下の問題を解決できることを見出し、本願発明を完成させるに至った。
【0010】
すなわち、本発明は以下の通りである。
(1) 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い、第1試薬および第2試薬を反応槽に添加する免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、反応を安定化し測定精度を向上させる方法、
(2) 第2試薬が、抗原または抗体で感作した粒子状不溶性担体を含む、(1)の方法、
(3) 測定が25℃以上37℃以下の温度条件で行われる、(1)または(2)の方法、
(4) 測定に使用する自動分析装置が、試薬を反応槽へ分注する際にチューブを介して連続的に分注する手段を有している、(1)〜(3)のいずれかの方法、
(5) 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行う免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、反応を安定化し測定精度を向上させるための、少なくとも第1試薬および第2試薬を含む免疫測定用キットであって、第1試薬の容積が第2試薬の容積よりも大きいキット、
(6) 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い、第1試薬と第2試薬を反応槽に添加する免疫測定法において、測定が行われる間、第1試薬を保冷しておき第2試薬を室温から反応温度の範囲の温度条件におくことにより、反応を安定化し測定精度を向上させる方法、
(7) 第2試薬が、抗原または抗体で感作した粒子状不溶性担体を含む、(6)の方法、
(8) 測定が25℃以上37℃以下の温度条件で行われる、(6)または(7)の方法、
(9) 測定に使用する自動分析装置が、試薬を反応槽へ分注する際にチューブを介して連続的に分注する手段を有している、(6)〜(8)のいずれかの方法、および
(10) 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づき、反応槽に第1試薬と第2試薬が添加される免疫測定が可能な自動分析装置において、第1試薬を冷却する収納手段と第2試薬を室温から反応温度で保持する収納手段を含み、反応を安定化し測定精度を向上させ得る免疫測定法に用いる自動分析装置。
【0011】
【発明の実施の形態】
本発明は、緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い、第1試薬および第2試薬を反応槽に添加する免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、反応を安定化し測定精度を向上させる方法である。また、本発明は、緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い第1試薬と第2試薬を反応槽に添加する免疫測定法において、第1試薬を保冷しておき、第2試薬を室温から反応温度の範囲の温度条件におくことにより、反応を安定化し測定精度を向上させる方法である。
【0012】
測定に使用する自動分析装置は、免疫測定法に適用可能な生化学検査用自動分析装置であり、連続分注方式によりチューブを介して試薬を反応槽へ分注する機構を採用しているものである。すなわち、装置内または装置外に試薬を設置する手段を備え、チューブを通って試薬が装置に備えられた反応槽内に連続的に分注される装置である。チューブを通しての試薬の分注は、例えばぺリスタポンプ等のポンプと切替弁との組み合わせにより行われる。このような装置として、市販のものが種々挙げられるが、例えば株式会社日立製作所の日立自動分析装置7250形、自動分析装置7450形、自動分析装置7350形等が挙げられる。
【0013】
本発明の方法は、ラテックス粒子、ベントナイト、コロジオン、カオリン、固定羊赤血球等などの不溶性担体を利用した凝集法による免疫測定法に適用することができる。凝集法による免疫測定において、不溶性担体は測定対象が抗原である場合には抗体で感作、すなわち担体表面に抗体を結合させ、測定対象が抗体である場合には、抗原で感作すればよい。本発明は、反応系がわずかに不安定でも鋭敏にその影響を受ける高感度測定系において特に有効である。高感度測定系として、例えば、不溶性担体として特開2001−289853号公報に記載の大きさの異なる2つ以上の粒子を使用した測定系が挙げられる。凝集法による免疫測定法であって、測定を自動分析装置を用いて行う方法において、反応槽内で抗原または抗体感作担体と測定対象抗体または測定対象抗原が結合し形成された凝集塊を光学的に捉えることにより抗原または抗体を測定する。すなわち凝集塊に可視光から近赤外域の光を照射し、吸光度変化又は散乱光の強度変化を検出して担体粒子の凝集の程度を測定する。この際、測定方式として、One Point法、Two Point法、Three Point法、Rate法等があるが、本発明の方法はいずれの測定方式にも適用することができる。反応槽にあらかじめ被験試料を分注しておき、そこに第1試薬および第2試薬を分注し反応を行わせ凝集度を測定することにより、凝集度を指標に被験試料中の測定対象抗原または測定対象抗体を定量することができる。第1試薬および第2試薬の添加の順序は限定されないが、好ましくは第1試薬を第2試薬に先んじて分注するか、または第1試薬と第2試薬を同時に分注する。この際、あらかじめ、測定対象の濃度がわかっている複数の試料を用いて測定対象濃度と凝集度を関連付けた標準曲線を作成しておくことにより、標準曲線に基づいて被験試料中の測定対象物の濃度を算出することができる。
【0014】
第1試薬としては緩衝液が挙げられる、他の安定化試薬、保護試薬等を含んでいてもよい。第2試薬としては測定対象である抗原または抗体に特異的に結合する抗体または抗原を感作させた上述の粒子が挙げられ、他の安定化試薬、保護試薬等を含んでいてもよい。
【0015】
本発明の第1の態様として、反応系に添加する第1試薬と第2試薬の容積比を第2試薬の割合が少なくなるようにすることが挙げられ、この場合、第2試薬1容に対して、第1試薬を1.5容以上、好ましくは2容以上にすればよい。凝集反応は、抗原または抗体で感作した担体の量、担体への抗原または抗体の感作量、被験試料と担体の量比等を適宜調整することにより至適化することができ、第1試薬と第2試薬の添加容積比に応じて、これらの量は容易に至適化することができる。
【0016】
本発明の第2の態様として、自動分析装置中に第1試薬と第2試薬を設置する際に、第1試薬を通常どおり保冷庫に入れ冷却しておき、第2試薬を保冷せずに室温においておくか、あらかじめ抗原抗体反応が行われる反応温度近辺まで加温しておくことが挙げられる。自動分析装置に温度を調節することが可能な複数の試薬庫を設置し、一方を冷却し第1試薬を収納し、もう一方を加温し第2試薬を収納しておいてもよいし、第2試薬を測定時に装置外に出して室温条件においてもよい。この場合、添加する第1試薬の量と第2試薬の量は同じでもよいし、第1の態様と第2の態様を組合わせて、第1試薬の添加量と第2試薬の添加量を変えてもよい。
【0017】
また、測定時の反応の温度条件は特に限定されないが、25℃から37℃、好ましくは37℃である。該温度に制御された恒温槽中で反応を行えばよい。温度制御については、ウォーターバス方式またはエアバス方式のいずれも可能であり、ウォーターバスまたはエアバスを用いて反応試薬を添加する反応槽の温度を制御すればよい。
【0018】
測定時の動作タイミングは、具体的には、被検試料と第1試薬の混合後180秒以上のインキュベーションを置き、第2試薬を添加した時点から30〜60秒後に吸光度の計測を開始し、60〜300秒間の測定を行うものである。好ましくは被検試料と第1試薬の混合後インキュベーションは240〜300秒間、第2試薬添加時点から30〜60秒後に測定を開始し、120〜240秒間の測定を行うものである。
【0019】
本発明の方法により測定される物質は、免疫測定法にて測定可能なものであれば、その他の制限を受けるものではない。例えばC反応性蛋白(CRP)などの血漿蛋白成分を挙げることができるが、これらに限定されるものではない。また、被検試料としても限定されるものではなく、血清、血漿、尿、髄液等の体液や飲食物またはその抽出液などを挙げることができるが、これらに限定されるものではない。
【0020】
さらに、本発明は緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行う免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上、好ましくは2容以上とすることにより、反応を安定化し測定精度を向上させるための、少なくとも第1試薬および第2試薬を含む免疫測定用キットであって、第1試薬の容積が第2試薬の容積よりも大きいキットをも包含する。第1試薬の容積が第2試薬の容積よりも大きいとは、キット中に含まれる第1試薬の容積と第2試薬の量が、測定時に添加する量試薬の容積比に対応しており、いずれかの試薬のみを無駄にすることなく同時に使い切れる量を意味する。キット中でこれらの試薬は適当なボトルに入れた状態で供給される。
【0021】
さらに、本発明は緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法に用いる自動分析装置であって、反応槽に第1試薬と第2試薬が添加される免疫測定法に用いる自動分析装置において、第1試薬を冷却する収納手段と第2試薬を室温から反応温度で保持する収納手段を含み、反応を安定化し測定精度を向上させ得る免疫測定法に用いる自動分析装置をも包含する。
【0022】
【実施例】
以下、本発明を実施例に基づき、より具体的に説明する。もっとも、本発明は下記実施例に限定されるものではない。
実施例1 CRP測定試薬における測定精度確認試験 その1
第1試薬としてグリシンを基本とした緩衝液(pH7.0)、第2試薬には抗ヒトCRPウサギポリクローナル抗体をポリスチレンラテックス粒子に感作したものを分散浮遊液状としたものを用いる。この際ポリスチレンラテックス粒子は平均粒子径が約0.20μmのものおよび0.07μmのものを併せて用いた。第2試薬の調製法はCambiasoらの方法(Methods in Enzymology Vol.74; SectionI,B[6]:106−139)に従い、グリシン緩衝液中で抗体とポリスチレンラテックスの規定量を混合し、室温で60分間放置することにより感作を行い、遠心操作により余剰の抗体を除去した後、ウシ血清アルブミンを含むグリシン緩衝液によりポリスチレンラテックス粒子表面の抗体未感作部分のブロッキング処理を施し、再び遠心操作により抗体感作ラテックス粒子を集め、グリシン緩衝液中に分散浮遊させることにより調製した。以上の試薬を実施例および比較例共通に使用する。
【0023】
検量線作成用の標準物質として、ヒトCRP精製抗原を正常ヒト血清にて希釈して調製したCRP標準品を使用した。CRP標準品は血漿蛋白国際標準品CRM470に準拠して値付けしたものであり、0.5,2,4,16,32mg/dLを用意した。0mg/dLとして生理食塩液を使用した。また、同様にして測定精度確認試験用の試料として約10mg/dLの試料を用意した。
【0024】
本発明の実施例において、第1試薬量と第2試薬量の比が2:1となるよう、第1試薬量180μL,第2試薬量90μL,検体量2μL(条件1とする)、および、第1試薬量と第2試薬量の比が3:1となるよう、第1試薬量240μL,第2試薬量80μL,検体量2μL(条件2とする)、比較例として、第1試薬量と第2試薬量の比が1:1となる、第1試薬量150μL,第2試薬量150μL,検体量3μLのそれぞれの条件で測定を行った。
【0025】
測定には、チューブ方式である生化学検査用自動分析装置日立7250形を使用し、検体および第1試薬の混合から37℃5分間のインキュベーションの後、第2試薬の添加により反応を開始させ、反応開始後30秒から180秒間の反応を波長570nmにおける吸光度変化として測定する設定とした。検体量および試薬量を除く条件は、実施例、比較例とも共通のもので測定した。第1試薬および第2試薬ともに8℃の保冷庫に保持して測定を行った。
実施例、比較例の条件毎に、前記条件によりCRP標準品各濃度の吸光度変化量を求め、CRP濃度と吸光度変化量の関係を示す検量線グラフをそれぞれ作成した。これを図1に示した。
【0026】
CRP標準品の測定後、装置を30分間停止する。その後、測定精度確認試験用の試料を検体として、それぞれの条件につき連続20回の測定を行い、それぞれの平均値、標準偏差、変動係数を求めた。これを表1に示した。また、測定値の変動を表すグラフを図2に示した。
【0027】
【表1】

Figure 2004028954
【0028】
また、測定値の変動をグラフで確認すると、実施例では測定回数に拘らずほぼ横這いであり、測定値の変動は分析精度に由来するものと考えられるが、比較例では測定回数1〜5回の間で測定値の上昇が見られ、その後安定する傾向が確認できる。
【0029】
これは、測定開始前、装置が停止していた30分間に装置内のチューブに滞留していた第2試薬が保冷状態にない部分のみ温められ、測定に影響を及ぼしたものと考えられる。このとき、試薬が設置された試薬庫の温度は約10℃、試薬が分注されるチューブ先端部は、30℃を超えていた。したがって、測定開始直後の測定においては約30℃温まった試薬が分注され、その後保冷状態にあった試薬が送り出されることで試薬の温度が徐々に低下し、試薬温度の安定に伴って測定値の安定が見られるようになったものである。
【0030】
実施例2 CRP測定試薬における測定精度確認試験 その2
本発明が試薬の製造ロットが異なっても適用できることを確認するため、第2試薬としてロット違いで3種類(Lot.10102、Lot.14107およびLot.18112)を用い、実施例1と同様な方法で測定を行った。添加容積比が1:1の例は比較例である。
【0031】
表2〜表4に第2試薬のロット毎に各条件について、第1試薬、第2試薬および検体の量ならびに連続20回の測定を行った場合のそれぞれの平均値、標準偏差および変動係数を示した。また、図3に検量線を、図4に測定値の変動を示した。
【0032】
【表2】
Figure 2004028954
【0033】
【表3】
Figure 2004028954
【0034】
【表4】
Figure 2004028954
表2、表3、表4、図3および図4に示されるように、第2試薬のロットが異なっても同様の結果が得られた。
【0035】
実施例3 CRP測定試薬における測定精度確認試験 その3
第1試薬および第2試薬容積を同じにし、第2試薬を通常の試薬庫設置により8℃(比較例)、室温設置により27℃(条件1)、恒温槽設置により37℃(条件2)に維持し、実施例1と同様に検討を行った。
表5に各条件について、第1試薬、第2試薬および検体の量ならびに連続20回の測定を行った場合のそれぞれの平均値、標準偏差および変動係数を示した。また、図5に検量線を、図6に測定値の変動を示した。
【0036】
【表5】
Figure 2004028954
表5、図5および図6に示されるように、第2試薬の温度を8℃から27℃または37℃に上昇させることにより、反応が安定し測定精度が向上した。
【0037】
【発明の効果】
実施例1および2が示すように、本発明の方法に従って、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、生化学検査用自動分析装置における免疫測定法による試薬において、外的な変動要因の影響を軽減し、より正確な測定を実現することができる。また、実施例3が示すように、本発明の方法に従って、第1試薬を保冷しておき、第2試薬を室温から反応温度に置いておくことにより、外的な変動要因の影響を軽減し、より正確な測定を実現することができる。
【図面の簡単な説明】
【図1】実施例1および比較例におけるCRP濃度と規定時間内の吸光度変化量の関係を示した図である。
【図2】実施例1及び比較例におけるCRP濃度10mg/dLの試料を20回連続測定した場合の変動を測定回数毎に示す図である。
【図3】実施例2および比較例におけるCRP濃度と規定時間内の吸光度変化量の関係を示した図である。
【図4】実施例2及び比較例におけるCRP濃度10mg/dLの試料を20回連続測定した場合の変動を測定回数毎に示す図である。
【図5】実施例3および比較例におけるCRP濃度と規定時間内の吸光度変化量の関係を示した図である。
【図6】実施例3及び比較例におけるCRP濃度10mg/dLの試料を20回連続測定した場合の変動を測定回数毎に示す図である。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention aims to stabilize the reaction and improve the measurement accuracy by mitigating the influence of external fluctuation factors in a two-solution immunoassay reagent applicable to an automatic analyzer for biochemical testing. About the method.
[0002]
[Prior art]
The immunoassay is applied to clinical tests as a method for quantifying antigenic substances or antibodies contained in body fluids such as serum, plasma, urine, and cerebrospinal fluid.Currently, methods adapted to automatic analyzers for biochemical tests are widely used. are doing. In recent years, immunoassays for clinical tests have been realized with high sensitivity by using an insoluble carrier or the like, and the measurement accuracy has been significantly improved. For example, many reagents capable of performing highly sensitive measurement using a technique using two or more types of insoluble carrier particles having different particle sizes (Japanese Patent No. 2588174) have been developed.
However, in a reagent whose measurement accuracy has been improved by increasing the sensitivity, slight fluctuation of an external factor may affect the measurement due to high sensitivity. In particular, there has been a problem that the measured values fluctuate when the temperature conditions are unstable.
[0003]
There are various types of automatic analyzers for biochemistry used for measurement, and they can be divided into two types according to the method of dispensing reagents. One is a method in which a reagent is dispensed by pipetting, in which a part called a reagent dispensing probe sucks a reagent from a reagent bottle placed in a reagent storage and discharges it to a reaction tank. That is, the reagent dispensing probe moves between the reagent storage and the reaction tank, aspirates and dispenses the reagent, and dispenses several different reagents with one probe. The other is a method in which a reagent bottle placed in a reagent storage is dispensed into a reaction tank via a tube, and a reagent is continuously sucked from the reagent bottle and continuously discharged into the reaction tank. . That is, the reagent is aspirated at one end of the tube and dispensed at the other end, and only one reagent is operated per tube. In any method, the suction and discharge of the reagent are performed by a syringe method, and the switching between suction and discharge is performed by an electromagnetic valve.
Among these two types of devices, the tube type device has a problem in that the measured values are not stable for a while after the start of the measurement and accurate quantification cannot be performed.
[0004]
[Problems to be solved by the invention]
SUMMARY OF THE INVENTION It is an object of the present invention to solve the problem that a measured value is not stable after the start of measurement in measurement by an automatic analyzer for biochemical testing. Specifically, by providing a method for stabilizing the reaction in order to suppress a decrease in measurement accuracy caused by a change in temperature of the entire reaction solution due to the addition of the second reagent in the measurement by the automatic analyzer for biochemical testing, is there.
[0005]
[Means for Solving the Problems]
The present inventors have conducted intensive studies in order to solve the above-mentioned problem, and found the cause of the instability of the measured value. That is, in any of the reagent dispensing probe system and the tube system of the above-mentioned automatic analyzer for biochemistry, the reagent storage for installing the reagent in order to stably maintain the reagent is often cooled, and the reagent is not used. Keep at low temperature. However, in the reagent dispensing section, cooling is practically impossible. In particular, the reaction tank, which is the reaction site, is in a thermostat kept at 37 ° C., and the tip of the reagent dispensing section close to the reaction tank is relatively Has been placed in a hot condition.
[0006]
In the pipetting type apparatus, the timing from the suction to the discharge of the reagent is constant, and the reagent is always dispensed under the same conditions. However, in the tube type apparatus, the measurement is started from a state where the apparatus is stopped. The temperature of the dispensed reagent differs between the case and the case where the reagent is continuously discharged. That is, when the apparatus is stopped, the reagent in the tube connecting the reaction tank from the cool box stays in the tube and is kept at room temperature, so when the apparatus is started, it is initially heated to room temperature. The reagent is added to the reaction system, but the reagent which has been kept at low temperature in the cool box is added to the reaction system without being heated.
[0007]
When the immunoassay is performed in a tube-type apparatus, a test sample and a first reagent, which is a buffer, are first mixed in a reaction tank, and the mixture is generally incubated at 37 ° C. for about 5 minutes. Is warmed to 37 ° C. Thereafter, a second reagent containing a component directly involved in the antigen-antibody reaction is added. When the temperature of the second reagent is low, the temperature of the reaction solution as a whole is fluctuated, thereby affecting the reaction. Therefore, the reaction system is established in consideration of such a temperature change. However, as described above, if there is a difference in the temperature of the second reagent added to the reaction system immediately after the operation of the apparatus and after a certain period of time, the reaction system will not be stable, and the measured value will be different. This causes a decrease in measurement accuracy.
[0008]
Based on this elucidation of the cause, the inventors of the present application conducted studies to reduce the effect of temperature change due to the addition of the second reagent. As a result, in order to stabilize the temperature conditions during the reaction, the amount of the first reagent was It has been found that the ratio of the amount of the second reagent may be modified.
That is, it has been found that by increasing the ratio of the first reagent heated to 37 ° C. prior to the reaction, it is possible to suppress a change in the temperature of the entire reaction solution caused by a temperature difference between the second reagents. The present inventors have conducted intensive studies on the volume ratio of the first reagent and the second reagent, and as a result, completed the present invention.
[0009]
Furthermore, the inventors of the present application have tried to solve the above-mentioned problem of the decrease in measurement accuracy due to the instability of the reaction system from another approach, and have not increased the temperature of the second reagent in the cool box and raised the temperature in advance. As a result, it was found that the problem of a decrease in measurement accuracy could be solved, and the present invention was completed.
[0010]
That is, the present invention is as follows.
(1) An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer, and the first reagent and the second reagent are used. In the immunoassay to be added to the reaction tank, the reaction is stabilized and the measurement accuracy is improved by setting the amount of the reagent added to the reaction system to 1.5 volumes or more of the first reagent with respect to 1 volume of the second reagent. Method,
(2) The method according to (1), wherein the second reagent comprises a particulate insoluble carrier sensitized with an antigen or an antibody.
(3) The method according to (1) or (2), wherein the measurement is performed under a temperature condition of 25 ° C. or more and 37 ° C. or less.
(4) Any of (1) to (3), wherein the automatic analyzer used for measurement has a means for continuously dispensing via a tube when dispensing the reagent to the reaction tank. Method,
(5) An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the immunoassay is performed using an automatic analyzer and added to the reaction system. By making the amount of the first reagent 1.5 volumes or more with respect to 1 volume of the second reagent, the immunization including at least the first reagent and the second reagent for stabilizing the reaction and improving the measurement accuracy is performed. A measurement kit, wherein the volume of the first reagent is larger than the volume of the second reagent,
(6) An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer, and the first reagent and the second reagent are combined. In the immunoassay method to be added to the reaction tank, the first reagent is kept cool and the second reagent is kept at a temperature ranging from room temperature to the reaction temperature during the measurement, thereby stabilizing the reaction and improving the measurement accuracy. How to make
(7) The method according to (6), wherein the second reagent comprises a particulate insoluble carrier sensitized with an antigen or an antibody.
(8) The method according to (6) or (7), wherein the measurement is performed under a temperature condition of 25 ° C. or more and 37 ° C. or less.
(9) Any of (6) to (8), wherein the automatic analyzer used for the measurement has means for continuously dispensing via a tube when dispensing the reagent to the reaction tank. Method and (10) Automatic analysis capable of performing an immunoassay in which the first reagent and the second reagent are added to a reaction tank based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen. An automatic analyzer for use in an immunoassay method, which comprises a storage means for cooling a first reagent and a storage means for holding a second reagent at a reaction temperature from room temperature to a reaction temperature, thereby stabilizing a reaction and improving measurement accuracy.
[0011]
BEST MODE FOR CARRYING OUT THE INVENTION
The present invention relates to an immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer, and the first reagent and the second reagent are used. In the immunoassay method in which is added to the reaction vessel, the amount of the reagent added to the reaction system is 1.5 volumes or more of the first reagent to 1 volume of the second reagent, thereby stabilizing the reaction and improving the measurement accuracy. It is a way to make it. The present invention also relates to an immunoassay based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer and the first reagent and the second reagent are used. In the immunoassay method in which a reagent is added to a reaction tank, the first reagent is kept cool, and the second reagent is kept at a temperature in a range from room temperature to the reaction temperature, thereby stabilizing the reaction and improving the measurement accuracy. is there.
[0012]
The automatic analyzer used for measurement is an automatic analyzer for biochemical tests applicable to immunoassays, and has a mechanism that dispenses reagents to the reaction tank via tubes by a continuous dispensing method. It is. In other words, the apparatus is provided with means for installing a reagent inside or outside the apparatus, and the reagent is continuously dispensed through a tube into a reaction tank provided in the apparatus. The dispensing of the reagent through the tube is performed by a combination of a pump such as a peristaltic pump and a switching valve. As such an apparatus, there are various commercially available apparatuses, for example, Hitachi automatic analyzer 7250, automatic analyzer 7450, automatic analyzer 7350 and the like manufactured by Hitachi, Ltd.
[0013]
The method of the present invention can be applied to an immunoassay by an agglutination method using an insoluble carrier such as latex particles, bentonite, collodion, kaolin, fixed sheep erythrocytes and the like. In the immunoassay by the agglutination method, the insoluble carrier may be sensitized with an antibody when the measurement target is an antigen, that is, the antibody may be bound to the surface of the carrier, and when the measurement target is an antibody, the insoluble carrier may be sensitized with the antigen. . The present invention is particularly effective in a highly sensitive measurement system which is sensitively affected even if the reaction system is slightly unstable. As a high-sensitivity measurement system, for example, a measurement system using two or more particles having different sizes described in JP-A-2001-289853 as an insoluble carrier is exemplified. An immunoassay method based on an agglutination method, in which a measurement is performed using an automatic analyzer, wherein an agglutinate formed by binding an antigen or an antibody-sensitized carrier to a measurement target antibody or a measurement target antigen in a reaction tank is optically analyzed. The antigen or antibody is measured by capturing the target. That is, the aggregate is irradiated with light in the visible to near-infrared range, and a change in absorbance or a change in intensity of scattered light is detected to measure the degree of aggregation of the carrier particles. At this time, the measuring method includes the One Point method, the Two Point method, the Three Point method, the Rate method, and the like, but the method of the present invention can be applied to any measuring method. The test sample is previously dispensed into the reaction tank, the first reagent and the second reagent are dispensed there, the reaction is performed, and the degree of agglutination is measured. Alternatively, the antibody to be measured can be quantified. The order of addition of the first reagent and the second reagent is not limited, but preferably the first reagent is dispensed prior to the second reagent, or the first reagent and the second reagent are dispensed simultaneously. At this time, by preparing a standard curve in which the concentration of the measurement target and the degree of agglutination are associated using a plurality of samples whose concentrations of the measurement target are known in advance, the target substance in the test sample is determined based on the standard curve. Can be calculated.
[0014]
The first reagent may include a buffer, other stabilizing reagents, protective reagents, and the like. Examples of the second reagent include the above-mentioned particles sensitized with an antibody or an antigen that specifically binds to the antigen or the antibody to be measured, and may include other stabilizing reagents, protective reagents, and the like.
[0015]
As a first aspect of the present invention, the volume ratio of the first reagent and the second reagent to be added to the reaction system is set so that the ratio of the second reagent is reduced. In this case, one volume of the second reagent is used. On the other hand, the volume of the first reagent may be 1.5 volumes or more, preferably 2 volumes or more. The agglutination reaction can be optimized by appropriately adjusting the amount of the carrier sensitized with the antigen or antibody, the amount of the antigen or antibody sensitized to the carrier, the ratio of the test sample to the carrier, and the like. Depending on the volume ratio of the reagent and the second reagent, these amounts can be easily optimized.
[0016]
As a second aspect of the present invention, when the first reagent and the second reagent are set in the automatic analyzer, the first reagent is put into a cool box as usual and cooled, and the second reagent is kept cool. This may be at room temperature or preheated to around the reaction temperature at which the antigen-antibody reaction takes place. A plurality of reagent chambers capable of controlling the temperature may be installed in the automatic analyzer, one of which may be cooled to store the first reagent, and the other may be heated to store the second reagent, The second reagent may be taken out of the apparatus at the time of measurement and kept at room temperature. In this case, the amount of the first reagent and the amount of the second reagent to be added may be the same, or the amount of the first reagent and the amount of the second reagent may be reduced by combining the first mode and the second mode. You may change it.
[0017]
Further, the temperature condition of the reaction at the time of measurement is not particularly limited, but is 25 ° C. to 37 ° C., preferably 37 ° C. The reaction may be performed in a thermostat controlled at the temperature. Regarding the temperature control, either a water bath method or an air bath method is possible, and the temperature of the reaction tank to which the reaction reagent is added may be controlled using the water bath or the air bath.
[0018]
The operation timing at the time of measurement, specifically, incubation of 180 seconds or more after mixing of the test sample and the first reagent, the measurement of the absorbance is started 30 to 60 seconds after the time of adding the second reagent, The measurement is performed for 60 to 300 seconds. Preferably, the incubation after the mixing of the test sample and the first reagent is started for 240 to 300 seconds, the measurement is started 30 to 60 seconds after the addition of the second reagent, and the measurement is performed for 120 to 240 seconds.
[0019]
The substance measured by the method of the present invention is not subject to any other restrictions as long as it can be measured by an immunoassay. Examples include, but are not limited to, plasma protein components such as C-reactive protein (CRP). In addition, the test sample is not limited, and examples thereof include body fluids such as serum, plasma, urine, and cerebrospinal fluid, foods and drinks, and extracts thereof, but are not limited thereto.
[0020]
Furthermore, the present invention relates to an immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the immunoassay is performed using an automatic analyzer. The amount of the first reagent is 1.5 volumes or more, preferably 2 volumes or more, per 1 volume of the second reagent, so that the amount of the reagent to be added to the first reagent is at least 1 volume for stabilizing the reaction and improving measurement accuracy. Also included is an immunoassay kit including a reagent and a second reagent, wherein the volume of the first reagent is larger than the volume of the second reagent. When the volume of the first reagent is larger than the volume of the second reagent, the volume of the first reagent and the amount of the second reagent included in the kit correspond to the volume ratio of the reagent added during measurement, It means the amount that can be used at the same time without wasting only one of the reagents. These reagents in the kit are supplied in suitable bottles.
[0021]
Furthermore, the present invention relates to an automatic analyzer used for an immunoassay based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the first reagent and the second reagent are contained in a reaction tank. An automatic analyzer used for the added immunoassay includes an accommodating means for cooling the first reagent and an accommodating means for holding the second reagent at room temperature to the reaction temperature, thereby stabilizing the reaction and improving the measurement accuracy. It also includes an automatic analyzer used for the method.
[0022]
【Example】
Hereinafter, the present invention will be described more specifically based on examples. However, the present invention is not limited to the following examples.
Example 1 Measurement accuracy confirmation test for CRP measurement reagent 1
As the first reagent, a buffer solution (pH 7.0) based on glycine is used. As the second reagent, an anti-human CRP rabbit polyclonal antibody sensitized to polystyrene latex particles is used as a dispersion suspension liquid. At this time, polystyrene latex particles having an average particle diameter of about 0.20 μm and 0.07 μm were used together. According to the method of Cambiaso et al. (Methods in Enzymology Vol. 74; Section I, B [6]: 106-139), the second reagent is prepared by mixing the antibody and polystyrene latex in a glycine buffer at room temperature. After sensitization by leaving it for 60 minutes, and removing excess antibody by centrifugation, blocking treatment of the antibody-unsensitized portion of the polystyrene latex particle surface with a glycine buffer containing bovine serum albumin was performed, followed by centrifugation again. Was prepared by dispersing and suspending antibody-sensitized latex particles in a glycine buffer. The above reagents are commonly used in Examples and Comparative Examples.
[0023]
As a standard substance for preparing a calibration curve, a CRP standard prepared by diluting a purified human CRP antigen with normal human serum was used. The CRP standard was priced based on the plasma protein international standard CRM470, and 0.5, 2, 4, 16, and 32 mg / dL were prepared. Physiological saline was used as 0 mg / dL. Similarly, a sample of about 10 mg / dL was prepared as a sample for a measurement accuracy confirmation test.
[0024]
In the embodiment of the present invention, the first reagent amount is 180 μL, the second reagent amount is 90 μL, the sample amount is 2 μL (condition 1), and the ratio of the first reagent amount to the second reagent amount is 2: 1. The first reagent amount is 240 μL, the second reagent amount is 80 μL, and the sample amount is 2 μL (condition 2) so that the ratio of the first reagent amount to the second reagent amount is 3: 1. The measurement was performed under the conditions of the first reagent amount of 150 μL, the second reagent amount of 150 μL, and the sample amount of 3 μL, where the ratio of the second reagent amount is 1: 1.
[0025]
For the measurement, using a tube type automatic analyzer for biochemical test Hitachi 7250 type, after mixing the sample and the first reagent at 37 ° C. for 5 minutes, the reaction was started by adding the second reagent, It was set to measure the reaction from 30 seconds to 180 seconds after the start of the reaction as a change in absorbance at a wavelength of 570 nm. The conditions except for the amount of the sample and the amount of the reagent were measured in the same manner as in Examples and Comparative Examples. The measurement was carried out by holding both the first reagent and the second reagent in a cold storage at 8 ° C.
The amount of change in absorbance at each concentration of the CRP standard product was determined under the above conditions for each of the conditions of the examples and comparative examples, and calibration curve graphs showing the relationship between the CRP concentration and the amount of change in absorbance were created. This is shown in FIG.
[0026]
After measuring the CRP standard, the device is stopped for 30 minutes. Then, using the sample for the measurement accuracy confirmation test as a sample, continuous 20 measurements were performed for each condition, and the average value, standard deviation, and coefficient of variation were determined. This is shown in Table 1. FIG. 2 is a graph showing the fluctuation of the measured value.
[0027]
[Table 1]
Figure 2004028954
[0028]
Also, when the fluctuation of the measured value is confirmed by a graph, it is almost flat regardless of the number of measurements in the example, and it is considered that the fluctuation of the measured value is derived from the analysis accuracy. The measured value increases during the period, and then a tendency to stabilize can be confirmed.
[0029]
This is considered to be due to the fact that only the part where the second reagent stayed in the tube in the apparatus was not kept in a cold state for 30 minutes while the apparatus was stopped before the measurement was started, which affected the measurement. At this time, the temperature of the reagent storage in which the reagent was set was about 10 ° C., and the temperature at the tip of the tube into which the reagent was dispensed exceeded 30 ° C. Therefore, in the measurement immediately after the start of the measurement, the reagent warmed at about 30 ° C. is dispensed, and then the reagent that has been kept cool is sent out, so that the temperature of the reagent gradually decreases, and the measured value is reduced as the reagent temperature stabilizes. It is now that stability has been seen.
[0030]
Example 2 Measurement accuracy confirmation test for CRP measurement reagent Part 2
In order to confirm that the present invention can be applied even when the production lot of the reagent is different, a method similar to that of Example 1 was used by using three different lots (Lot. 10102, Lot. 14107 and Lot. 18112) as the second reagent. Was measured. An example in which the addition volume ratio is 1: 1 is a comparative example.
[0031]
Tables 2 to 4 show, for each condition of each lot of the second reagent, the amounts of the first reagent, the second reagent, and the sample, and the respective average values, standard deviations, and coefficients of variation when performing 20 consecutive measurements. Indicated. FIG. 3 shows the calibration curve, and FIG. 4 shows the fluctuation of the measured value.
[0032]
[Table 2]
Figure 2004028954
[0033]
[Table 3]
Figure 2004028954
[0034]
[Table 4]
Figure 2004028954
As shown in Table 2, Table 3, Table 4, FIGS. 3 and 4, similar results were obtained even when the lot of the second reagent was different.
[0035]
Example 3 Measurement accuracy confirmation test for CRP measurement reagent Part 3
The first reagent volume and the second reagent volume are made the same, and the second reagent is set to 8 ° C. (comparative example) by installing a normal reagent storage, 27 ° C. (condition 1) by installing at room temperature, and 37 ° C. (condition 2) by installing a constant temperature bath. It was maintained and examined in the same manner as in Example 1.
Table 5 shows, for each condition, the amounts of the first reagent, the second reagent, and the sample, as well as the average value, standard deviation, and coefficient of variation when performing 20 consecutive measurements. FIG. 5 shows a calibration curve, and FIG. 6 shows fluctuations of measured values.
[0036]
[Table 5]
Figure 2004028954
As shown in Table 5, FIG. 5 and FIG. 6, by raising the temperature of the second reagent from 8 ° C. to 27 ° C. or 37 ° C., the reaction was stabilized and the measurement accuracy was improved.
[0037]
【The invention's effect】
As shown in Examples 1 and 2, according to the method of the present invention, the amount of the reagent added to the reaction system is set to 1.5 volumes or more of the first reagent with respect to 1 volume of the second reagent, whereby the biochemical test is performed. In the reagent by the immunoassay method in the automatic analyzer for use, the influence of external fluctuation factors can be reduced, and more accurate measurement can be realized. In addition, as shown in Example 3, by keeping the first reagent cold and keeping the second reagent at room temperature to the reaction temperature according to the method of the present invention, the influence of external fluctuation factors is reduced. , More accurate measurement can be realized.
[Brief description of the drawings]
FIG. 1 is a diagram showing the relationship between the CRP concentration and the amount of change in absorbance within a specified time in Example 1 and Comparative Example.
FIG. 2 is a diagram showing, for each of the number of measurements, fluctuations in a case where a sample having a CRP concentration of 10 mg / dL was continuously measured 20 times in Example 1 and Comparative Example.
FIG. 3 is a diagram showing the relationship between the CRP concentration and the amount of change in absorbance within a specified time in Example 2 and Comparative Example.
FIG. 4 is a diagram showing, for each of the number of measurements, fluctuations in a case where samples having a CRP concentration of 10 mg / dL in Example 2 and Comparative Example were continuously measured 20 times.
FIG. 5 is a graph showing the relationship between the CRP concentration and the amount of change in absorbance within a specified time in Example 3 and Comparative Example.
FIG. 6 is a diagram showing, for each of the number of measurements, fluctuations in a case where a sample having a CRP concentration of 10 mg / dL was continuously measured 20 times in Example 3 and Comparative Example.

Claims (10)

緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い、第1試薬および第2試薬を反応槽に添加する免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、反応を安定化し測定精度を向上させる方法。An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer, and the first reagent and the second reagent are placed in a reaction tank. In the immunoassay method to be added, a method in which the amount of the reagent added to the reaction system is 1.5 volumes or more of the first reagent to 1 volume of the second reagent, thereby stabilizing the reaction and improving the measurement accuracy. 第2試薬が、抗原または抗体で感作した粒子状不溶性担体を含む、請求項1に記載の方法。The method according to claim 1, wherein the second reagent comprises a particulate insoluble carrier sensitized with an antigen or an antibody. 測定が25℃以上37℃以下の温度条件で行われる、請求項1または2に記載の方法。The method according to claim 1, wherein the measurement is performed under a temperature condition of 25 ° C. or more and 37 ° C. or less. 測定に使用する自動分析装置が、試薬を反応槽へ分注する際にチューブを介して連続的に分注する手段を有している、請求項1〜3のいずれか1項に記載の方法。The method according to any one of claims 1 to 3, wherein the automatic analyzer used for measurement has means for continuously dispensing via a tube when dispensing the reagent to the reaction tank. . 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行う免疫測定法において、反応系に添加する試薬の量を第2試薬1容に対して第1試薬を1.5容以上とすることにより、反応を安定化し測定精度を向上させるための、少なくとも第1試薬および第2試薬を含む免疫測定用キットであって、第1試薬の容積が第2試薬の容積よりも大きいキット。An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen. An immunoassay kit containing at least a first reagent and a second reagent for stabilizing the reaction and improving the measurement accuracy by setting the amount of the first reagent to 1.5 volumes or more per 1 volume of the second reagent A kit wherein the volume of the first reagent is larger than the volume of the second reagent. 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づく免疫測定法であって、測定を自動分析装置を用いて行い、第1試薬と第2試薬を反応槽に添加する免疫測定法において、測定が行われる間、第1試薬を保冷しておき第2試薬を室温から反応温度の範囲の温度条件におくことにより、反応を安定化し測定精度を向上させる方法。An immunoassay method based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, wherein the measurement is performed using an automatic analyzer, and the first reagent and the second reagent are placed in a reaction tank. In the immunoassay to be added, a method in which the first reagent is kept cool and the second reagent is kept at a temperature in a range from room temperature to the reaction temperature during the measurement, thereby stabilizing the reaction and improving the measurement accuracy. 第2試薬が、抗原または抗体で感作した粒子状不溶性担体を含む、請求項6に記載の方法。7. The method of claim 6, wherein the second reagent comprises a particulate insoluble carrier sensitized with an antigen or an antibody. 測定が25℃以上37℃以下の温度条件で行われる、請求項6または7に記載の方法。The method according to claim 6, wherein the measurement is performed under a temperature condition of 25 ° C. or more and 37 ° C. or less. 測定に使用する自動分析装置が、試薬を反応槽へ分注する際にチューブを介して連続的に分注する手段を有している、請求項6〜8のいずれか1項に記載の方法。The method according to any one of claims 6 to 8, wherein the automatic analyzer used for the measurement has means for continuously dispensing via a tube when dispensing the reagent to the reaction tank. . 緩衝液を含む第1試薬および抗体もしくは抗原を含む第2試薬を用いる凝集法に基づき、反応槽に第1試薬と第2試薬が添加される免疫測定が可能な自動分析装置において、第1試薬を冷却する収納手段と第2試薬を室温から反応温度で保持する収納手段を含み、反応を安定化し測定精度を向上させ得る免疫測定法に用いる自動分析装置。In an automatic analyzer capable of performing an immunoassay in which a first reagent and a second reagent are added to a reaction tank based on an agglutination method using a first reagent containing a buffer and a second reagent containing an antibody or an antigen, the first reagent An automatic analyzer for use in an immunoassay method, comprising a storage means for cooling the sample and a storage means for holding the second reagent at a reaction temperature from room temperature to stabilize the reaction and improve the measurement accuracy.
JP2002189569A 2002-06-28 2002-06-28 Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method Pending JP2004028954A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002189569A JP2004028954A (en) 2002-06-28 2002-06-28 Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002189569A JP2004028954A (en) 2002-06-28 2002-06-28 Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method

Publications (1)

Publication Number Publication Date
JP2004028954A true JP2004028954A (en) 2004-01-29

Family

ID=31183950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002189569A Pending JP2004028954A (en) 2002-06-28 2002-06-28 Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method

Country Status (1)

Country Link
JP (1) JP2004028954A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101881777A (en) * 2010-06-30 2010-11-10 深圳市国赛生物技术有限公司 Assay method of high sensitivity C-reactive protein (HS-CRP) and HS-CRP assay kit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101881777A (en) * 2010-06-30 2010-11-10 深圳市国赛生物技术有限公司 Assay method of high sensitivity C-reactive protein (HS-CRP) and HS-CRP assay kit

Similar Documents

Publication Publication Date Title
US20110081731A1 (en) Method of Assaying Antigen and Reagent Therefor
AU2002313319B2 (en) Carrier particle latex for assay reagent and assay reagent
CN101893619B (en) Method for improving stability of latex suspension liquid
Gella et al. Latex agglutination procedures in immunodiagnosis
JP3513075B2 (en) Immunoassay and reagent therefor
AU669904B2 (en) Initial rate photometric method for immunoassay
WO2021199178A1 (en) Latex agglutination method-mediated target substance measurement method, and reagent therefor
CN102369441B (en) Immunoassay method and reagent therefor
JP2004028954A (en) Method for stabilizing reaction and enhancing measurement accuracy in immunity measuring method
AU2004225599B2 (en) Turbidimetric immunoassy for lipoprotein (a) and reagent therefor
CN107490675B (en) A kind of Immunoturbidimetric kit and detection method
CN112798794A (en) Alpha 1 acid glycoprotein detection kit
JP7327944B2 (en) Method for measuring target substance by latex agglutination method and its reagent
JPH0448265A (en) Immunoassay
WO2024038863A1 (en) Immunoassay method and reagent
JPH0814581B2 (en) Antigen or antibody quantification method
EP0710838A1 (en) Immunoassay method
JP2002048796A (en) Method for detecting or measuring presence of immunologically reactive material
CN105891502A (en) Colloidal gold immunocolorimetry kit for detecting alpha1-microglobulin (AMG) and preparation method of kit
JPH04309864A (en) Quantitative measurement for antigen or antibody
CN117890578A (en) Single reagent for detecting trypsinogen 2 (Try-2) and preparation method thereof
JPH0815258A (en) Immunological determination reagent and determination method
JPH08233816A (en) Immunoassay
JPS63115061A (en) Immunoassay
JPH0833396B2 (en) Immunoassay reagent and immunoassay method using the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050526

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070219

A131 Notification of reasons for refusal

Effective date: 20070320

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070521

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071009